FLT3 and acute myeloid leukemia: We provide a comprehensive overview of the heterogeneity and impact of FLT3‐ITD mutations in AML by assessing the numerical variation, variant allele distribution and the relationship with clinical features as well as with FLT3‐ITD molecular characteristics like length, sequence and integration site correlated to overall survival in two independent AML cohorts.